A recent review highlighted the dual nature of these effects: while anti-TNF agents generally offer a protective effect against cardiovascular events in this population, their use, particularly at high doses, in patients with pre-existing heart failure or a history of myocardial infarction may be ineffective or potentially harmful [65]. Here, TNF is linked to myocardial infarction.